{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:18Z","timestamp":1788484398755,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.revmed.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:42:16Z","timestamp":1782160936000},"page":"500-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1081-7928","authenticated-orcid":false,"given":"Raffaele","family":"Barile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1356-8423","authenticated-orcid":false,"given":"Cinzia","family":"Rotondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3750-5934","authenticated-orcid":false,"given":"Giulio","family":"Giancaspro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-9105","authenticated-orcid":false,"given":"Valeria","family":"Rella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco P.","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addolorata","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.revmed.2026.06.005_bib0260","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/rheumatology\/keab190","article-title":"Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis","volume":"60","author":"Bairkdar","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.revmed.2026.06.005_bib0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00296-016-3530-3","article-title":"A critical view on cardiovascular risk in systemic sclerosis","volume":"37","author":"Psarras","year":"2017","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.revmed.2026.06.005_bib0270","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10067-014-2666-3","article-title":"Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study","volume":"33","author":"Papagoras","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2026.06.005_bib0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/23971983211053246","article-title":"Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF\/HFA definition","volume":"7","author":"Bruni","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"10.1016\/j.revmed.2026.06.005_bib0280","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/23971983231163413","article-title":"Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation\/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment","volume":"8","author":"Bruni","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"10","key":"10.1016\/j.revmed.2026.06.005_bib0285","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.revmed.2026.06.005_bib0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/23971983241313096","article-title":"Cardiac involvement in systemic sclerosis: a critical review of knowledge gaps and opportunities","volume":"10","author":"Jones","year":"2025","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.revmed.2026.06.005_bib0295","doi-asserted-by":"crossref","first-page":"152229","DOI":"10.1016\/j.semarthrit.2023.152229","article-title":"Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: a systematic review and meta-analysis","volume":"62","author":"Fairley","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.revmed.2026.06.005_bib0300","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/23971983211034074","article-title":"Incidence, risk factors and outcomes of conduction and rhythm disorders in systemic sclerosis: a US population-based cohort study","volume":"6","author":"Radwan","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"issue":"21","key":"10.1016\/j.revmed.2026.06.005_bib0305","doi-asserted-by":"crossref","first-page":"12963","DOI":"10.3390\/ijms232112963","article-title":"Arrhythmias and conduction disturbances in patients with systemic sclerosis - a systematic literature review","volume":"23","author":"Vrancianu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.revmed.2026.06.005_bib0310","article-title":"Evaluation of systemic sclerosis primary heart involvement and chronic heart failure in the European Scleroderma Trials and Research cohort","author":"Gy\u00f6rfi","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.revmed.2026.06.005_bib0315","doi-asserted-by":"crossref","first-page":"e0153012","DOI":"10.1371\/journal.pone.0153012","article-title":"Prognostic role of ventricular ectopic beats in systemic sclerosis: a prospective cohort study shows ECG indexes predicting the worse outcome","volume":"11","author":"De Luca","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.revmed.2026.06.005_bib0320","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1093\/rheumatology\/keac065","article-title":"Myocardial fibrosis and arrhythmic burden in systemic sclerosis","volume":"61","author":"Ross","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.revmed.2026.06.005_bib0325","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/rheumatology\/kez658","article-title":"Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis","volume":"59","author":"De Luca","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.revmed.2026.06.005_bib0330","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.semarthrit.2013.07.006","article-title":"Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","volume":"43","author":"Pieroni","year":"2014","journal-title":"Semin. Arthritis Rheum"},{"key":"10.1016\/j.revmed.2026.06.005_bib0335","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3390\/life15101608","article-title":"Arrhythmias in systemic sclerosis: a call for interdisciplinary teams","volume":"15","author":"Costan","year":"2025","journal-title":"Life"},{"issue":"5","key":"10.1016\/j.revmed.2026.06.005_bib0340","first-page":"1303","article-title":"Prognostic importance of cardiac arrhythmias in systemic sclerosis","volume":"12","author":"Kostis","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.revmed.2026.06.005_bib0345","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/art.1780281110","article-title":"Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients","volume":"28","author":"Ferri","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.revmed.2026.06.005_bib0350","doi-asserted-by":"crossref","first-page":"e78808","DOI":"10.1371\/journal.pone.0078808","article-title":"Right bundle branch block: a predictor of mortality in early systemic sclerosis","volume":"8","author":"Draeger","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.revmed.2026.06.005_bib0355","first-page":"319","article-title":"Domperidone and risk of ventricular arrhythmia and cardiac death: a systematic review and meta-analysis","volume":"39","author":"Leelakanok","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.revmed.2026.06.005_bib0360","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.2169\/internalmedicine.9471-22","article-title":"The treatment of systemic sclerosis-related pericarditis","volume":"61","author":"Yoshimi","year":"2022","journal-title":"Intern Med"},{"issue":"7","key":"10.1016\/j.revmed.2026.06.005_bib0365","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/0002-9343(76)90582-9","article-title":"Pericardial fluid analysis in scleroderma (systemic sclerosis)","volume":"60","author":"Gladman","year":"1976","journal-title":"Am J Med"},{"issue":"15","key":"10.1016\/j.revmed.2026.06.005_bib0370","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","article-title":"Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis","volume":"72","author":"Tenn\u00f8e","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.revmed.2026.06.005_bib0375","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/art.30614","article-title":"Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias","volume":"63","author":"Yiu","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"17","key":"10.1016\/j.revmed.2026.06.005_bib0380","doi-asserted-by":"crossref","first-page":"e013405","DOI":"10.1161\/JAHA.119.013405","article-title":"Cardiovascular manifestations of systemic sclerosis: a Danish nationwide cohort study","volume":"8","author":"Butt","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.revmed.2026.06.005_bib0385","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3899\/jrheum.201025","article-title":"Increased prevalence of moderate to severe mitral and aortic valve dysfunction in systemic sclerosis: a case-control study","volume":"48","author":"Narvaez","year":"2021","journal-title":"J. Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2026.06.005_bib0390","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/art.30283","article-title":"Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition","volume":"63","author":"Mok","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2026.06.005_bib0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2023.06.003","article-title":"Subclinical coronary atherosclerosis, detected by CT coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis","volume":"115","author":"Rotondo","year":"2023","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.revmed.2026.06.005_bib0400","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"10.1016\/j.revmed.2026.06.005_bib0405","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/ehjci\/jeac120","article-title":"Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study","volume":"24","author":"Knight","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.revmed.2026.06.005_bib0410","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ehjci\/jeac094","article-title":"Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis","volume":"24","author":"Gotschy","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.revmed.2026.06.005_bib0415","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/23971983211040608","article-title":"NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis","volume":"7","author":"Jha","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.revmed.2026.06.005_bib0420","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2147\/JMDH.S295478","article-title":"The role of the multidisciplinary health care team in the management of patients with systemic sclerosis","volume":"15","author":"Farina","year":"2022","journal-title":"J Multidiscip Healthc"},{"issue":"6","key":"10.1016\/j.revmed.2026.06.005_bib0425","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.revmed.2026.06.005_bib0430","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3899\/jrheum.100480","article-title":"Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis","volume":"38","author":"Bernardo","year":"2011","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2026.06.005_bib0435","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/1756-185X.12952","article-title":"Cardiac tamponade and severe pericardial effusion in systemic sclerosis: report of nine patients and review of the literature","volume":"20","author":"Fern\u00e1ndez Morales","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.revmed.2026.06.005_bib0440","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.resinv.2024.11.003","article-title":"Advancements in the treatment of interstitial lung disease in systemic sclerosis with the approval of mycophenolate mofetil","volume":"62","author":"Takada","year":"2024","journal-title":"Respir Investig"},{"key":"10.1016\/j.revmed.2026.06.005_bib0445","doi-asserted-by":"crossref","first-page":"102330","DOI":"10.1016\/j.jaut.2019.102330","article-title":"Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: a prospective cohort study","volume":"106","author":"De Luca","year":"2020","journal-title":"J. Autoimmun"},{"issue":"5","key":"10.1016\/j.revmed.2026.06.005_bib0450","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5114\/reum.2022.120755","article-title":"Heart disease in the course of systemic sclerosis","volume":"60","author":"Nowakowska-P\u0142aza","year":"2022","journal-title":"Reumatologia"},{"issue":"7","key":"10.1016\/j.revmed.2026.06.005_bib0455","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2665-9913(21)00107-7","article-title":"Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial","volume":"3","author":"Ebata","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.revmed.2026.06.005_bib0460","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ejhf.3467","article-title":"Add-on rituximab for primary heart involvement associated with systemic sclerosis: a step forward in the tailored treatment of myocarditis?","volume":"27","author":"De Santis","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.revmed.2026.06.005_bib0465","doi-asserted-by":"crossref","first-page":"e005493","DOI":"10.1136\/rmdopen-2025-005493","article-title":"Combination therapy of rituximab and mycophenolate in patients with systemic sclerosis and primary cardiac involvement refractory to cyclophosphamide: a retrospective exploratory analysis of 10 cases","volume":"11","author":"Adjailia","year":"2025","journal-title":"RMD Open"},{"key":"10.1016\/j.revmed.2026.06.005_bib0470","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.revmed.2026.06.005_bib0475","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/ejhf.3445","article-title":"Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry","volume":"26","author":"Lund","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.revmed.2026.06.005_bib0480","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/13816128113199990555","article-title":"Micro- and macrovascular treatment targets in scleroderma heart disease","volume":"20","author":"Dimitroulas","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.revmed.2026.06.005_bib0485","doi-asserted-by":"crossref","first-page":"e004918","DOI":"10.1136\/rmdopen-2024-004918","article-title":"Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis","volume":"10","author":"Gu\u00e9don","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.revmed.2026.06.005_bib0490","article-title":"Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world cohort study on tolerability and discontinuation","author":"Kaenmuang","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2026.06.005_bib0495","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1093\/rheumatology\/keac674","article-title":"Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study","volume":"62","author":"Ninagawa","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2026.06.005_bib0500","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.revmed.2026.06.005_bib0505","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/jcdd11090274","article-title":"Progression, management, and outcome of aortic valve stenosis in systemic sclerosis: a case series","volume":"11","author":"Vergara","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"issue":"1198","key":"10.1016\/j.revmed.2026.06.005_bib0510","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/postmj\/qgae169","article-title":"Fibrosis mechanisms in systemic sclerosis and new potential therapies","volume":"101","author":"Barile","year":"2025","journal-title":"Postgrad Med J"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866326006302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:41:39Z","timestamp":1788482499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866326006302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0248866326006302"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.06.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}